Novo Nordisk
NVO
#26
Rank
NZ$682.50 B
Marketcap
$151.10
Share price
1.73%
Change (1 day)
-14.97%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): NZ$28.88 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are NZ$39.69 Billion. In 2023 the company made an earning of NZ$27.27 Billion, an increase over its 2022 earnings that were of NZ$17.30 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$28.88 B5.9%
2023 NZ$27.27 B57.64%
2022 NZ$17.30 B5.35%
2021 NZ$16.42 B12.47%
2020 NZ$14.60 B13.07%
2019 NZ$12.91 B-3.35%
2018 NZ$13.36 B1.79%
2017 NZ$13.12 B4.52%
2016 NZ$12.55 B9.42%
2015 NZ$11.47 B8.24%
2014 NZ$10.60 B3.45%
2013 NZ$10.25 B19.02%
2012 NZ$8.61 B15.21%
2011 NZ$7.47 B17.71%
2010 NZ$6.35 B24.78%
2009 NZ$5.08 B10.62%
2008 NZ$4.60 B55.97%
2007 NZ$2.94 B7.07%
2006 NZ$2.75 B18.18%
2005 NZ$2.33 B11.33%
2004 NZ$2.09 B
2002 NZ$1.27 B-14.39%
2001 NZ$1.49 B-52.82%
2000 NZ$3.16 B250%
1999 NZ$0.90 B31.21%
1998 NZ$0.68 B34.31%
1997 NZ$0.51 B11.46%
1996 NZ$0.46 B9.03%
1995 NZ$0.42 B-3.15%
1994 NZ$0.43 B-0.67%
1993 NZ$0.43 B45.38%
1992 NZ$0.30 B-13.81%
1991 NZ$0.35 B37.12%
1990 NZ$0.25 B-0.79%
1989 NZ$0.25 B26.2%
1988 NZ$0.20 B24.97%
1987 NZ$0.16 B-0.9%
1986 NZ$0.16 B-7.78%
1985 NZ$0.17 B24.87%
1984 NZ$0.14 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$12.27 B-61.09%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.94 B-43.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.17 Billion-138.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.09 B-58.48%๐Ÿ‡ซ๐Ÿ‡ท France